StockData
Purple Biotech Ltd. logo

Purple Biotech Ltd. (PPBT) stock

PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30
$1.71+0.03 (+1.79%)

Close on Nov 17, 2026Market cap $1.59MP/E 0.0Yield –

Purple Biotech operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2023 it was -$22.27M. The highest annual figure on record is -$4.07M in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$22.27M–
FY2022Dec 31, 2022-$22.60M–
FY2021Dec 31, 2021-$17.93M–
FY2020Dec 31, 2020-$12.61M–
FY2019Dec 31, 2019-$7.16M–
FY2018Dec 31, 2018-$7.83M–
FY2017Dec 31, 2017-$11.97M–
FY2016Dec 31, 2016-$7.18M–
FY2015Dec 31, 2015-$4.07M–

More Purple Biotech figures

See a number that looks wrong?